TMEM161A and non-small cell lung carcinoma: In a previous study on sharing TCRs in non-small-cell lung cancer, TMEM161A was identified as a novel tumor-associated antigen; its overexpression in tumors and its cross-reactive epitopes were from EBV LMP2A and E. coli (Chiou et al. 2021).